Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2020 | Future advances in DCIS: de-escalation of hormonal therapy

Ivana Sestak, PhD, Wolfson Institute of Preventive Medicine, Queen Mary University London, London, UK, explores the future of treatment of patients with ductal carcinoma in situ (DCIS), including potential de-escalation of endocrine therapy, and the importance of identifying patients who will have an invasive recurrence of disease, namely by using biomarkers that identify with aggressive disease. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).